Valuation: Almirall, S.A.

Market Cap 2.44B 2.78B 2.27B 2.08B 3.91B 267B 3.97B 26.94B 10.52B 131B 10.43B 10.2B 455B P/E 2026 *
28.4x
P/E 2027 * 20.4x
Enterprise Value 2.33B 2.65B 2.17B 1.99B 3.73B 255B 3.79B 25.72B 10.05B 126B 9.95B 9.74B 434B EV / Sales 2026 *
1.89x
EV / Sales 2027 * 1.61x
Free-Float
35.93%
Yield 2026 *
1.81%
Yield 2027 * 1.88%
1 day+1.27%
1 week+4.87%
Current month-0.53%
1 month-0.71%
3 months-11.95%
6 months-12.09%
Current year-12.77%
1 week 10.74
Extreme 10.74
11.96
1 month 10.52
Extreme 10.52
11.96
Current year 10.52
Extreme 10.52
13.98
1 year 10.06
Extreme 10.06
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
14.96
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 2022-11-01
Director of Finance/CFO 53 2025-08-30
Chief Tech/Sci/R&D Officer - 2021-07-06
Director TitleAgeSince
Director/Board Member - 2013-12-31
Director/Board Member - 2015-12-31
Chairman - 2022-05-05
Date Insider Type Main position Quantity % Market Cap.
6/23/23 Buy

Executive/Senior Manager

3,000 0.0017%
6/22/23 Buy 4,340 0.0024%
6/22/23 Buy

Executive/Senior Manager

6,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+1.27%+4.87%+4.28%+31.22% 2.78B
+0.86%+1.43%+47.17%+163.68% 1,067B
+1.59%+4.09%+56.51%+52.50% 635B
+0.95%+1.91%+36.30%+82.78% 458B
+1.60%+6.25%+37.00%+31.03% 347B
-0.60%+1.52%+36.67%+41.41% 295B
-0.14%+0.60%+17.29%+18.74% 262B
+0.09%-2.82%-29.09%-39.57% 216B
+1.22%+2.66%+22.66%+59.87% 203B
-1.18%-3.70%+11.28%+67.52% 161B
Average +0.57%+1.68%+24.01%+50.92% 364.63B
Weighted average by Cap. +0.76%+1.95%+35.97%+79.06%

Financials

2026 *2027 *
Net sales 1.23B 1.4B 1.14B 1.05B 1.97B 135B 2B 13.58B 5.31B 66.28B 5.26B 5.14B 229B 1.36B 1.54B 1.26B 1.16B 2.17B 149B 2.21B 14.98B 5.85B 73.12B 5.8B 5.67B 253B
Net income 84.19M 95.85M 78.29M 71.84M 135M 9.23B 137M 930M 363M 4.54B 360M 352M 15.69B 116M 133M 108M 99.31M 187M 12.76B 189M 1.29B 502M 6.27B 497M 487M 21.69B
Net Debt -111M -126M -103M -94.32M -177M -12.12B -180M -1.22B -477M -5.96B -472M -462M -20.6B -255M -290M -237M -218M -409M -27.97B -415M -2.82B -1.1B -13.75B -1.09B -1.07B -47.54B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,108
Date Price Change Volume
26-07-24 €11.20 +1.27% 311,260
26-07-23 €11.06 +1.10% 137,877
26-07-22 €10.94 +0.37% 180,948
26-07-21 €10.90 -0.37% 109,869
26-07-20 €10.94 +2.43% 117,903
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
11.20EUR
Average target price
14.51EUR
Spread / Average Target
+29.54%

Quarterly revenue - Rate of surprise